Cost-Effectiveness of Trimodal Therapy and Radical Cystectomy for Muscle-Invasive Bladder Cancer.
- Published in:
- JAMA Network Open, 2025, v. 8, n. 6, p. e2517056, doi. 10.1001/jamanetworkopen.2025.17056
- By:
- Publication type:
- Article
Works by Wymer, Kevin M.
Results: 6
1
2
The Role of Ureteroscopy, Ultra-Mini-Percutaneous Nephrolithotomy, and Mini-Percutaneous Nephrolithotomy in the Treatment of Urolithiasis: What Is the Role for Each in the Current Era of Stone Practice?
- Published in:
- AUANews, 2022, v. 27, n. 10, p. 3
- By:
- Publication type:
- Article
3
Are adverse events during surgery for benign prostatic hyperplasia device related? A review of the MAUDE database.
- Published in:
- Urologia Journal, 2024, v. 91, n. 2, p. 249, doi. 10.1177/03915603241240646
- By:
- Publication type:
- Article
4
Comparative cost‐effectiveness of neoadjuvant chemotherapy regimens for muscle‐invasive bladder cancer: Results according to VESPER data.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 24, p. 4194, doi. 10.1002/cncr.34502
- By:
- Publication type:
- Article
5
Comparative cost-effectiveness of contemporary treatment strategies for stage IIA seminoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 3, p. 468, doi. 10.1093/jnci/djad211
- By:
- Publication type:
- Article
6
A Serum C-Reactive Protein and Procalcitonin-Based Risk Score to Predict Urinary Infection in Patients with Obstructive Urolithiasis Undergoing Decompression.
- Published in:
- Journal of Endourology, 2021, v. 35, n. 3, p. 369, doi. 10.1089/end.2020.0163
- By:
- Publication type:
- Article